• AMNOG dossiers / early benefit assessment • Digital applications / fast track application process• Strategy consulting: market access• Specialities list (CH)

Appointed by the Chancellor of Rheinische Friedrich-Wilhelms-University, Bonn, Germany

• AMNOG dossiers • Systematic reviews • Meta-analyses • Health Technology Assessments • Pharmacoeconomic studies• Epidemiological models• Supply studies• Gap-analyses• SWOT-analyses

• Healthcare research• Health Technology Assessments• Healtheconomic studies• Analyses of insurance funds’ data• National and international scientific cooperations

• Representation of the interests of the 140,000 office-based physicians and psychotherapists in legislative procedures • Contract negotiations with the umbrella organizations of the statutory health insurance funds and other social service providers in the field of pharmaceuticals • Deputy Member representing providers in decision panel of the Federal Joint Committee (G-BA)• Member representing providers in subcommittees “Drugs” and “Rules of procedure” of the G-BA• Member of the expert group "Off-label use of drugs" on behalf of the Federal Institute for Drugs and Medical Devices (BfArM)• Managing Director, Working Committee Medicines of the G-BA

• Pharmacoeconomic analyses and modelling• Cost-effectiveness analyses• Budget impact analyses• Cost of illness analyses• Meta-analyses